METAvivor Research and Support Inc., a volunteer-led non-profit organization, invites grant applications for its 2025 cycle. METAvivor aims to fund innovative research specifically targeted at metastatic breast cancer (MBC) with the goal of transforming it from a terminal condition to a chronic, manageable disease while maintaining the quality of life for those affected. METAvivor has provided grants totaling over $37 million since 2009 to support this mission.
The 2025 grant cycle includes three awards:
All individuals with a clinical doctoral degree or with a doctoral degree who are actively engaged in areas of metastatic breast cancer research and treatment are eligible to apply.